- Abridge and Kaiser Permanente debut Care Signals
- Built to Serve: The Day That Reminds Us Why We Chose Dentistry
- Journalists Catch You Up on Fauci Hearing, Peptides, and Kids’ Caffeine Consumption
- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
Michigan healthcare freedom community forum
Interlochen Public Radio interviewed personnel from the Michigan State Police (MSP) Forensic Science Division (FSD) and Harm Reduction Michigan about the changing nature of illegal drugs being confiscated in Michigan:
https://www.michigan.gov/msp/divisions/forensic-science
Purer meth, less pure opioids, more cocaine hit Michigan, testing reveals
By Maxwell Howard of Interlochen Public Radio | February 14, 2026Mexican drug cartels are shipping purer forms of meth into rural Michigan, replacing the drugs that were once made in home labs and full of impurities, police and lab testing data shows.
Meanwhile, opioids have been cut with more impurities that can render overdose treatment ineffective and cocaine use is on the rise, the data shows.
The lab results show rural parts of the state are rife with methamphetamine, cities have more cocaine, and opioids are everywhere in lesser amounts.
While Michigan’s drug overdose deaths have fallen from a high of 3,000 in 2021 to just more than 1,900 in 2024, the most recent state data shows, drug use remains high. Some 269,000 Michiganders 12 and older reported using illicit drugs other than marijuana in 2023 and 2024, the most recent federal data shows.
Local production of meth has grinded to a halt within the last five years, said Elaine Dougherty, lab manager at the Michigan State Police Bridgeport crime lab.
“Now, we get the crystal meth from the drug cartels,” said Doughterty. “It's not made from Sudafed anymore. It's not made in pop bottles anymore. It's literally made in factories in Mexico.”
In Grayling, about 60% of the drugs tested at that crime lab are meth, while Marquette comes in over 80%. Opioids and cocaine each make up roughly 10% to 15% in those labs.
While cocaine is a smaller percentage of the drugs tested across the state, Dougherty said the drug is more popular than it’s been in years, driven in part by increased production in South and Central America.
The number of tests run for cocaine at State Police crime labs statewide has almost doubled within the last three years — from 15% to 28%. That follows global trends showing the number of global cocaine users has grown to 25 million people in 2023, up from 17 million a decade earlier, according to the United Nation’s 2025 World Health Report.
That report says an estimated 3,708 tons of cocaine were manufactured in 2023, increasing by almost 1,000 tons from the year before. The increased supply has increased access and purity of the drug for users.
Opioids, Dougherty said, are the most heavily adulterated drugs on Michigan’s market, with around 20% of synthetic fentanyl samples containing xylazine, a sedative often paired with opioids for its similar effects.
Xylazine does not act on the same opioid receptors pathway, so opioid overdose reversal medication such as Naloxone does not work.
“We were rarely seeing large amounts of xylazine in a sample,” said Doughtery. “I know on the East Coast, they were seeing samples with five times as much xylazine as fentanyl.”
Xylazine levels peaked in Michigan in early 2025, according to MSP lab data, being found in 34% of fentanyl samples. That gradually declined at the end of the year.
Another non-opioid veterinary sedative, medetomidine, has increased from being non-existent in the last year to being found in over 12% of fentanyl samples. That drug behaves much in the same way as xylazine, but is 100 times more potent.
In 2024, three overdoses in Michigan were linked to medetomidine, leading state health officials to raise the alarm.
Damage by xylazine can result in deep skin wounds by restricting blood flow and damaging tissue.
Staff at Traverse City’s Harm Reduction MI office report treating xylazine wounds occasionally — usually with groups and in small timeframes.
“If fentanyl with xylazine makes it to Traverse City, it's likely several people are ingesting it. Especially if you always get your drugs from the same source,” said Dougherty.
One reason for that risk, she said, is that local dealers often don’t know what’s in the drugs.
“The dealers don't know when their stuff has xylazine in it,” said Dougherty. “In an odd way, (dealers) take pride in what they sell. So if they are saying they're selling cocaine, they want those customers to come back. So they want it to be cocaine that they're selling.”
Harm Reduction also tests drugs across the state, but at a different entry point than the State Police. While the state labs test drugs after they are confiscated, Harm Reduction MI tests drugs while they are on the street.
Director Pamela Lynch said most people usually find the nonprofit through word of mouth and come to test their drugs after a bad reaction. Harm Reduction’s testing data often includes more minute data than the state lab, which reports drug mixtures and cocktails.
Lynch’s lab data also reports different cocktails, but also reveals smaller adulterants — substances which appear in drugs incidentally or for little known purposes.
Around two months back, Lynch said, a woman brought in a substance to be tested after her boyfriend had an especially bad reaction and had trouble communicating. The sample later came back with results of PVC plastic.
“A lot of times, people know there's a lot of stuff in there that doesn't belong in there,” said Lynch.
Common adulterants include caffeine, acetaminophen, lidocaine, antidepressants and sugars. Sometimes, the substances are unexpected.
“We even had a sample recently with flower dye,” said Lynch. “The flower dye actually ends up making little spots on their skin.”
Whether knowing what’s in illegal drugs changes behavior — for dealers or people in active addiction — is unclear. But for Lynch, the purpose of her lab is to keep people as healthy as they can until a person is ready for recovery.
“They may think that they have a safe supply. They may trust their dealer,” said Lynch. “They all know they're buying fentanyl. They don't know that they're buying xylazine until they test it.”
This reporting is made possible by the Northern Michigan Journalism Collaborative, led by Bridge Michigan and Interlochen Public Radio, and funded by Press Forward Northern Michigan.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























